Previous 10 | Next 10 |
Insider buying decreased significantly last week with insiders purchasing $31.16 million of stock compared to $111.24 million in the week prior. Selling also decreased significantly with insiders selling $749.85 million of stock last week compared to $2.46 billion in the week prior. Sell/Bu...
La Jolla Pharmaceutical (NASDAQ: LJPC ) is up 3.2% postmarket following disclosure that director David Ramsay bought 47,000 shares in a series of transactions over the past few days. More news on: La Jolla Pharmaceutical Company, Healthcare stocks news, Stocks on the move, Read m...
La Jolla Pharmaceutical (NASDAQ: LJPC ) : Q2 GAAP EPS of -$0.57 misses by $0.13 . More news on: La Jolla Pharmaceutical Company, Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO, California, Aug. 06, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financ...
Merger activity increased last week with four new deals announced and seven deals closing. Over the past month, we have seen early signs of a pickup in new deals and two large deals announced in the energy and healthcare sectors. The acquisition of Noble Energy by Chevron was a significant d...
La Jolla Pharmaceutical's (NASDAQ: LJPC ) +13.1% AH, board appointed Larry Edwards as president & CEO. More news on: La Jolla Pharmaceutical Company, Healthcare stocks news, Stocks on the move, Read more ...
SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that its Board of Directors has appointed Larry Edwards as President and Chief Executive Officer. “Larry has an impressive track record bringing innovative treatments that a...
SAN DIEGO, California and WATERTOWN, Massachusetts, July 28, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening disease...
Merger activity remained steady last week with three new deals announced and two deals closing. There has not been any significant M&A activity this year in the energy sector with oil prices collapsing due to the COVID-19 pandemic. After choosing to walk away from a bidding war with Oc...
Merger activity increased last week with three new deals announced and one deal closing. The biggest highlight for last week was the acquisition of Maxim Integrated Products (MXIM) by Analog Devices (ADI) in an all-stock deal for $21 billion, which is the largest deal so far this year. The...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
La Jolla Pharmaceutical Company Website:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...